Essex Investment Management’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$498K Hold
20,182
0.08% 168
2025
Q4
$341K Hold
20,182
0.05% 182
2025
Q3
$439K Hold
20,182
0.07% 170
2025
Q2
$288K Sell
20,182
-237
-1% -$3.75K 0.05% 175
2025
Q1
$265K Sell
20,419
-4,023
-16% -$60.8K 0.06% 174
2024
Q4
$326K Sell
24,442
-2,810
-10% -$28.5K 0.06% 172
2024
Q3
$164K Hold
27,252
0.03% 203
2024
Q2
$89.7K Sell
27,252
-51,361
-65% -$180K 0.02% 230
2024
Q1
$295K Hold
78,613
0.06% 193
2023
Q4
$344K Sell
78,613
-31,403
-29% -$126K 0.07% 195
2023
Q3
$459K Buy
110,016
+43,095
+64% +$166K 0.07% 240
2023
Q2
$234K Buy
+66,921
New +$246K 0.03% 269

Other funds holding ETON

Essex Investment Management's ETON Position: Q1 2026 in Review

Essex Investment Management held its Eton Pharmaceutcials (ETON) position steady in Q1 2026 at 20,182 shares worth $498K. The position accounts for 0.08% of the portfolio, ranked #168.

Essex Investment Management first reported a position in ETON in Q2 2023 and has held it in 12 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Essex Investment Management held 20,182 shares of Eton Pharmaceutcials worth $498K as of Q1 2026.
  • Essex Investment Management left its Eton Pharmaceutcials share count unchanged in Q1 2026.
  • Eton Pharmaceutcials made up 0.08% of Essex Investment Management's portfolio in Q1 2026, its #168 holding.
  • Essex Investment Management first reported a position in Eton Pharmaceutcials in Q2 2023 and has held it in 12 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.